Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Esprinet

BATS-CHIXE:PRTM
Snowflake Description

Flawless balance sheet and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
PRTM
BATS-CHIXE
€185M
Market Cap
  1. Home
  2. GB
  3. Tech
Company description

Esprinet S.p.A., together with its subsidiaries, engages in the wholesale distribution of information technology (IT) and consumer electronics primarily in Italy, Spain, and Rest of Europe. The last earnings update was 55 days ago. More info.


Add to Portfolio Compare Print
  • Esprinet has significant price volatility in the past 3 months.
PRTM Share Price and Events
7 Day Returns
9.8%
BATS-CHIXE:PRTM
3.9%
GB Electronic
5.3%
GB Market
1 Year Returns
6%
BATS-CHIXE:PRTM
-4.5%
GB Electronic
-21.5%
GB Market
PRTM Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Esprinet (PRTM) 9.8% -17.5% -34.1% 6% -53.2% -63.6%
GB Electronic 3.9% -1.8% -14.1% -4.5% 23.7% 66.2%
GB Market 5.3% -6.5% -25.2% -21.5% -22.4% -21.9%
1 Year Return vs Industry and Market
  • PRTM outperformed the Electronic industry which returned -4.5% over the past year.
  • PRTM outperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -21.5% over the past year.
Price Volatility
PRTM
Industry
5yr Volatility vs Market

PRTM Value

 Is Esprinet undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Esprinet to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Esprinet.

BATS-CHIXE:PRTM Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Dividend Discount Model
Dividend Per Share Company Filings (2019-12-31) in EUR € 0.145
Payout Ratio Company Filings (2019-12-31) 3065.3%
Discount Rate (Cost of Equity) See below 11.4%
Perpetual Growth Rate 10-Year GB Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BATS-CHIXE:PRTM
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GB Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 8.2%
Electronic Unlevered Beta Simply Wall St/ S&P Global 1.1
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.104 (1 + (1- 24%) (103.54%))
1.319
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.32
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.53% + (1.319 * 8.23%)
11.39%

Discounted Cash Flow Calculation for BATS-CHIXE:PRTM using Dividend Discount Model Model

The calculations below outline how an intrinsic value for Esprinet is arrived at by discounting future dividends to their present value. This approach is used for finance firms where free cash flow is difficult to estimate (e.g. Banks/ Insurance firms).

If the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price.

See our documentation to learn about this calculation.

BATS-CHIXE:PRTM Gordon Growth Model
Calculation Result
Value per share = Expected dividends per share / (Discount Rate - Perpetual growth rate)
= €0.15 / (11.39% - 0.53%)
€1.2
BATS-CHIXE:PRTM Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BATS-CHIXE:PRTM represents 0.94869x of BIT:PRT
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.94869x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 1.34 x 0.94869
€1.27
Value per share (EUR) From above. €1.27
Current discount Discount to share price of €3.42
= -1 x (€3.42 - €1.27) / €1.27
-170%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Esprinet is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Esprinet's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Esprinet's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:PRTM PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in EUR €0.43
BIT:PRT Share Price ** BIT (2020-04-08) in EUR €3.61
United Kingdom of Great Britain and Northern Ireland Electronic Industry PE Ratio Median Figure of 22 Publicly-Listed Electronic Companies 17.3x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 747 Publicly-Listed Companies 13.27x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Esprinet.

BATS-CHIXE:PRTM PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BIT:PRT Share Price ÷ EPS (both in EUR)

= 3.61 ÷ 0.43

8.4x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Esprinet is good value based on earnings compared to the GB Electronic industry average.
  • Esprinet is good value based on earnings compared to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Esprinet's expected growth come at a high price?
Raw Data
BATS-CHIXE:PRTM PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 8.4x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
10.8%per year
United Kingdom of Great Britain and Northern Ireland Electronic Industry PEG Ratio Median Figure of 11 Publicly-Listed Electronic Companies 1.04x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 513 Publicly-Listed Companies 1.03x

*Line of best fit is calculated by linear regression .

BATS-CHIXE:PRTM PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 8.4x ÷ 10.8%

0.78x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Esprinet is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Esprinet's assets?
Raw Data
BATS-CHIXE:PRTM PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in EUR €7.13
BIT:PRT Share Price * BIT (2020-04-08) in EUR €3.61
United Kingdom of Great Britain and Northern Ireland Electronic Industry PB Ratio Median Figure of 33 Publicly-Listed Electronic Companies 1.89x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,322 Publicly-Listed Companies 1.13x
BATS-CHIXE:PRTM PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BIT:PRT Share Price ÷ Book Value per Share (both in EUR)

= 3.61 ÷ 7.13

0.51x

* Primary Listing of Esprinet.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Esprinet is good value based on assets compared to the GB Electronic industry average.
X
Value checks
We assess Esprinet's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Electronic industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Electronic industry average (and greater than 0)? (1 check)
  5. Esprinet has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

PRTM Future Performance

 How is Esprinet expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Esprinet expected to grow at an attractive rate?
  • Esprinet's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Esprinet's earnings growth is positive but not above the United Kingdom of Great Britain and Northern Ireland market average.
  • Esprinet's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:PRTM Future Growth Rates Data Sources
Data Point Source Value (per year)
BATS-CHIXE:PRTM Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 10.8%
BATS-CHIXE:PRTM Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 3.8%
United Kingdom of Great Britain and Northern Ireland Electronic Industry Earnings Growth Rate Market Cap Weighted Average 9%
United Kingdom of Great Britain and Northern Ireland Electronic Industry Revenue Growth Rate Market Cap Weighted Average 4%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.4%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:PRTM Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:PRTM Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 4,266 20 27 1
2020-12-31 4,110 18 25 1
2020-04-09
BATS-CHIXE:PRTM Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-12-31 3,952 158 22
2019-09-30 3,872 45 15
2019-06-30 3,751 -51 15
2019-03-31 3,665 -17 12
2018-12-31 3,571 128 14
2018-09-30 3,399 28 25
2018-06-30 3,318 122 26
2018-03-31 3,253 -16 27
2017-12-31 3,217 26 26
2017-09-30 3,244 -28 24
2017-06-30 3,234 -32 23
2017-03-31 3,172 35 25

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Esprinet's earnings are expected to grow by 10.8% yearly, however this is not considered high growth (20% yearly).
  • Esprinet's revenue is expected to grow by 3.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:PRTM Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Esprinet Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:PRTM Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 0.52 0.52 0.52 1.00
2020-12-31 0.48 0.48 0.48 1.00
2020-04-09
BATS-CHIXE:PRTM Past Financials Data
Date (Data in EUR Millions) EPS *
2019-12-31 0.43
2019-09-30 0.30
2019-06-30 0.30
2019-03-31 0.24
2018-12-31 0.27
2018-09-30 0.49
2018-06-30 0.50
2018-03-31 0.52
2017-12-31 0.51
2017-09-30 0.46
2017-06-30 0.44
2017-03-31 0.49

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Esprinet is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Esprinet's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Esprinet has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

PRTM Past Performance

  How has Esprinet performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Esprinet's growth in the last year to its industry (Electronic).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Esprinet's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
  • Esprinet's 1-year earnings growth exceeds its 5-year average (54.5% vs -10%)
  • Esprinet's earnings growth has exceeded the GB Electronic industry average in the past year (54.5% vs 6.9%).
Earnings and Revenue History
Esprinet's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Esprinet Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:PRTM Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 3,951.86 21.68 132.99
2019-09-30 3,872.44 15.06 130.91
2019-06-30 3,750.52 15.22 129.94
2019-03-31 3,665.41 12.37 130.67
2018-12-31 3,571.19 14.03 129.14
2018-09-30 3,399.38 25.45 125.66
2018-06-30 3,318.49 25.98 126.29
2018-03-31 3,253.03 26.74 130.52
2017-12-31 3,217.17 26.23 129.57
2017-09-30 3,244.12 23.94 133.65
2017-06-30 3,234.20 22.78 134.41
2017-03-31 3,172.32 25.33 130.35
2016-12-31 3,042.33 26.67 123.50
2016-09-30 2,814.35 24.02 119.03
2016-06-30 2,702.64 27.01 113.36
2016-03-31 2,691.93 28.11 109.71
2015-12-31 2,694.05 30.32 109.77
2015-09-30 2,561.28 27.51 108.83
2015-06-30 2,494.56 27.35 107.18
2015-03-31 2,396.11 25.23 105.11
2014-12-31 2,291.14 27.04 99.95
2014-09-30 2,147.04 27.12 94.38
2014-06-30 2,075.63 26.04 90.17
2014-03-31 2,033.55 26.89 86.85
2013-12-31 2,002.96 23.10 87.40
2013-09-30 1,950.99 22.74 87.42
2013-06-30 1,942.87 23.55 89.64

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Esprinet has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Esprinet used its assets less efficiently than the GB Electronic industry average last year based on Return on Assets.
  • Esprinet's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Esprinet's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Electronic industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Esprinet has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

PRTM Health

 How is Esprinet's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Esprinet's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Esprinet is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Esprinet's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Esprinet's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 15.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Esprinet Company Filings, last reported 3 months ago.

BATS-CHIXE:PRTM Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 357.46 96.91 463.78
2019-09-30 345.28 169.76 65.20
2019-06-30 346.18 224.36 120.95
2019-03-31 346.98 246.45 56.47
2018-12-31 342.90 152.81 381.31
2018-09-30 337.46 282.24 143.66
2018-06-30 337.29 153.96 123.56
2018-03-31 341.76 251.87 96.48
2017-12-31 338.19 177.86 296.97
2017-09-30 320.91 196.45 44.35
2017-06-30 317.90 232.80 78.33
2017-03-31 321.20 278.24 146.86
2016-12-31 317.96 189.93 285.93
2016-09-30 302.15 214.13 81.67
2016-06-30 300.68 135.65 115.14
2016-03-31 302.00 108.48 60.28
2015-12-31 297.61 100.09 280.09
2015-09-30 284.98 131.31 69.53
2015-06-30 282.16 93.27 60.39
2015-03-31 281.02 103.66 70.07
2014-12-31 274.87 99.17 225.17
2014-09-30 265.64 101.99 53.80
2014-06-30 261.48 35.08 59.37
2014-03-31 268.18 38.86 59.96
2013-12-31 259.83 42.10 176.89
2013-09-30 249.85 85.78 10.15
2013-06-30 246.44 61.39 28.87
  • Esprinet's level of debt (27.1%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (36.1% vs 27.1% today).
  • Debt is well covered by operating cash flow (163%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 4.7x coverage).
X
Financial health checks
We assess Esprinet's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Esprinet has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

PRTM Dividends

 What is Esprinet's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
3.74%
Current annual income from Esprinet dividends. Estimated to be 4.02% next year.
If you bought €2,000 of Esprinet shares you are expected to receive €75 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Esprinet's pays a higher dividend yield than the bottom 25% of dividend payers in United Kingdom of Great Britain and Northern Ireland (2.49%).
  • Esprinet's dividend is below the markets top 25% of dividend payers in United Kingdom of Great Britain and Northern Ireland (6.84%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:PRTM Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Electronic Industry Average Dividend Yield Market Cap Weighted Average of 16 Stocks 1.8%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 575 Stocks 5.5%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.5%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 6.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BATS-CHIXE:PRTM Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 0.15 1.00
2020-12-31 0.14 1.00
2020-04-09
BATS-CHIXE:PRTM Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-05-17 0.135 3.706
2019-02-14 0.135 4.003
2018-05-14 0.135 3.568
2018-05-09 0.135 3.083
2017-04-06 0.135 2.675
2016-04-07 0.150 2.338
2016-03-21 0.150 1.920
2015-05-05 0.125 1.594
2015-03-16 0.125 1.434
2014-04-04 0.089 1.303
2013-03-15 0.089 2.018
2013-02-14 0.089 2.532
2012-04-10 0.089 2.914
2012-02-14 0.089 2.237
2011-05-11 0.175 5.287
2011-04-27 0.175 3.072
2010-04-12 0.175 2.754
2009-04-14 0.155 2.157

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have fallen over the past 10 years.
Current Payout to shareholders
What portion of Esprinet's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3.2x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.5x coverage).
X
Income/ dividend checks
We assess Esprinet's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Esprinet afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Esprinet has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

PRTM Management

 What is the CEO of Esprinet's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Alessandro Cattani
COMPENSATION €546,000
AGE 56
TENURE AS CEO 15.8 years
CEO Bio

Mr. Alessandro Cattani has been Regional Deputy Chairman for Europe at Global Technology Distribution Council since July 2014. Mr. Cattani has been the Chief Executive Officer of Esprinet SpA since June 28, 2004 and served its Managing Director. Mr. Cattani started his professional career at Scriba S.p.A. where he served as Management Assistant until 1990. He serves as an Executive Director of Esprinet SpA. He also served as an Executive Director of Scriba S.p.A., where he was responsible for managing its information technology. From 1990 to 2000, he worked on the development of management consulting projects. Mr. Cattani obtained a Degree in Electronic Engineering and a Master (CEGA) from Bocconi University in Milan.

CEO Compensation
  • Alessandro's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Alessandro's remuneration is about average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team

Maurizio Rota

TITLE
Chairman & President
COMPENSATION
€546K
AGE
62
TENURE
1.9 yrs

Alessandro Cattani

TITLE
CEO & Executive Director
COMPENSATION
€546K
AGE
56
TENURE
15.8 yrs

Valerio Casari

TITLE
CFO, Head of Investor Relations & Director
COMPENSATION
€420K

Manfredi Tolomei

TITLE
Secretary
Board of Directors Tenure

Average tenure and age of the Esprinet board of directors in years:

7.6
Average Tenure
59
Average Age
  • The tenure for the Esprinet board of directors is about average.
Board of Directors

Maurizio Rota

TITLE
Chairman & President
COMPENSATION
€546K
AGE
62
TENURE
1.9 yrs

Alessandro Cattani

TITLE
CEO & Executive Director
COMPENSATION
€546K
AGE
56

Valerio Casari

TITLE
CFO, Head of Investor Relations & Director
COMPENSATION
€420K
TENURE
11 yrs

Mario Massari

TITLE
Independent Director
COMPENSATION
€77K
AGE
68
TENURE
11 yrs

Bettina Solimando

TITLE
Chairman of Board of Statutory Auditors
COMPENSATION
€27K
AGE
45
TENURE
1.9 yrs

Matteo Stefanelli

TITLE
Director
COMPENSATION
€71K

Marco Monti

TITLE
Director
COMPENSATION
€48K
TENURE
11 yrs

Chiara Mauri

TITLE
Independent Director
COMPENSATION
€54K
TENURE
7.6 yrs

Cristina Galbusera

TITLE
Independent Director
COMPENSATION
€66K
TENURE
6.9 yrs

Tommaso Stefanelli

TITLE
Director
COMPENSATION
€71K
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
22. Nov 19 Sell Valerio Casari Individual 19. Nov 19 19. Nov 19 -30,000 €4.05 €-120,305
22. Nov 19 Sell Valerio Casari Individual 18. Sep 19 19. Sep 19 -10,000 €3.79 €-37,832
22. Nov 19 Sell Valerio Casari Individual 19. Nov 19 19. Nov 19 -6,000 €3.99 €-23,805
14. Oct 19 Sell Valerio Casari Individual 09. Oct 19 10. Oct 19 -10,000 €3.76 €-37,271
23. Sep 19 Sell Valerio Casari Individual 18. Sep 19 19. Sep 19 -11,800 €3.79 €-44,615
X
Management checks
We assess Esprinet's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Esprinet has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

PRTM News

Simply Wall St News

PRTM Company Info

Description

Esprinet S.p.A., together with its subsidiaries, engages in the wholesale distribution of information technology (IT) and consumer electronics primarily in Italy, Spain, and Rest of Europe. The company distributes business to business IT products, such as hardware, software, and value-added services; consumer electronics; traditional IT products, including desktop PCs, notebooks, printers, copiers, servers, standard software, etc.; consumables comprising cartridges, tapes, toners, and magnetic supports; tablets, mobile devices, and their accessories; networking products consisting of modems, routers, and switches; and digital and entertainment products, such as TVS, photo cameras, video cameras, videogames, and MP3/MP4 readers. It also designs, produces, and distributes mobile devices accessories. The company serves IT resellers, including value-added resellers, system integrators/corporate resellers, dealers, independent and/or affiliated stores, general and/or specialist retailers, and sub-distributors. Esprinet S.p.A. is headquartered in Vimercate, Italy.

Details
Name: Esprinet S.p.A.
PRTM
Exchange: BATS-CHIXE
Founded:
€184,771,895
51,254,340
Website: http://www.esprinet.com
Address: Esprinet S.p.A.
Via Energy Park n. 20,
Vimercate,
20871,
Italy
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BIT PRT Ordinary Shares Borsa Italiana IT EUR 25. Jul 2001
DB EP4A Ordinary Shares Deutsche Boerse AG DE EUR 25. Jul 2001
LSE 0NFS Ordinary Shares London Stock Exchange GB EUR 25. Jul 2001
BATS-CHIXE PRTM Ordinary Shares BATS 'Chi-X Europe' GB EUR 25. Jul 2001
Number of employees
Current staff
Staff numbers
1,263
Esprinet employees.
Industry
Technology Distributors
Tech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/09 19:35
End of day share price update: 2020/04/08 00:00
Last estimates confirmation: 2020/02/17
Last earnings filing: 2020/02/14
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.